Comparison of methods to analyse susceptibility of German MDR/XDR Pseudomonas aeruginosa to ceftazidime/avibactam.

[1]  K. Mertens,et al.  Attributable deaths and disability-adjusted life-years caused by infections with antibiotic-resistant bacteria in the EU and the European Economic Area in 2015: a population-level modelling analysis , 2019, The Lancet. Infectious diseases.

[2]  R. Humphries,et al.  Performance of ceftazidime/avibactam susceptibility testing methods against clinically relevant Gram-negative organisms , 2018, The Journal of antimicrobial chemotherapy.

[3]  P. Tulkens,et al.  Loss of activity of ceftazidime-avibactam due to MexAB-OprM efflux and overproduction of AmpC cephalosporinase in Pseudomonas aeruginosa isolated from patients suffering from cystic fibrosis. , 2018, International journal of antimicrobial agents.

[4]  M. Castanheira,et al.  Frequency and antimicrobial susceptibility of Gram-negative bacteria isolated from patients with pneumonia hospitalized in ICUs of US medical centres (2015–17) , 2018, The Journal of antimicrobial chemotherapy.

[5]  J. Martínez,et al.  Mutation-Driven Evolution of Pseudomonas aeruginosa in the Presence of either Ceftazidime or Ceftazidime-Avibactam , 2018, Antimicrobial Agents and Chemotherapy.

[6]  M. Kresken,et al.  Performance of the Etest for Susceptibility Testing of Enterobacterales (Enterobacteriaceae) and Pseudomonas aeruginosa toward Ceftazidime-Avibactam , 2018, Journal of Clinical Microbiology.

[7]  C. MacDougall,et al.  Multidrug-Resistant Pseudomonas Infections: Hard to Treat, But Hope on the Horizon? , 2018, Current Infectious Disease Reports.

[8]  B. Kreiswirth,et al.  Verification of Ceftazidime-Avibactam and Ceftolozane-Tazobactam Susceptibility Testing Methods against Carbapenem-Resistant Enterobacteriaceae and Pseudomonas aeruginosa , 2017, Journal of Clinical Microbiology.

[9]  A. Mellmann,et al.  Susceptibility of MDR Pseudomonas aeruginosa to ceftolozane/tazobactam and comparison of different susceptibility testing methods , 2017, The Journal of antimicrobial chemotherapy.

[10]  A. Mellmann,et al.  Real-Time Genome Sequencing of Resistant Bacteria Provides Precision Infection Control in an Institutional Setting , 2016, Journal of Clinical Microbiology.

[11]  Carlos Juan,et al.  The increasing threat of Pseudomonas aeruginosa high-risk clones. , 2015, Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy.

[12]  Ronald N. Jones,et al.  Ceftazidime-Avibactam Activity against Multidrug-Resistant Pseudomonas aeruginosa Isolated in U.S. Medical Centers in 2012 and 2013 , 2015, Antimicrobial Agents and Chemotherapy.

[13]  D. Ehmann,et al.  Kinetics of Avibactam Inhibition against Class A, C, and D β-Lactamases , 2013, The Journal of Biological Chemistry.

[14]  S. Rasmussen,et al.  Identification of acquired antimicrobial resistance genes , 2012, The Journal of antimicrobial chemotherapy.

[15]  M. Falagas,et al.  Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. , 2012, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[16]  P. Nordmann,et al.  Biochemical Characterization of the Naturally Occurring Oxacillinase OXA-50 of Pseudomonas aeruginosa , 2004, Antimicrobial Agents and Chemotherapy.

[17]  Clinical,et al.  Performance standards for antimicrobial susceptibility testing , 2019 .

[18]  [Hygiene measures for infection or colonization with multidrug-resistant gram-negative bacilli. Commission recommendation for hospital hygiene and infection prevention (KRINKO) at the Robert Koch Institute (RKI)]. , 2012, Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz.

[19]  M J Ferraro.  Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically : approved standard , 2000 .

[20]  Clinical laboratory testing and in vitro diagnostic test systems. Susceptibility testing of infectious agents and evaluation of performance of antimicrobial susceptibility test devices , 2022 .